Chronic Obstructive Pulmonary Disease (COPD) will likely become the third leading cause of death by 2030 according to World Health Organization and continues to be a major cause of disability and rising health care costs worldwide.[1] The total cost of COPD in 2010 was $49.9 billion, including health care expenditures of $29.5 billion in direct health care costs, $8.0 billion in indirect morbidity costs, and $12.4 billion in indirect mortality costs in the United States.[2] These costs were the highest among common lung diseases. Current guidelines developed by Global Initiative for COPD (GOLD) recommend a maintenance therapy either with a long-acting muscarinic antagonist (LAMA) or a long-acting beta agonist (LABA) in symptomatic patients
The purpose of this paper is to discuss an exacerbation of Chronic Obstructive Pulmonary Disease (COPD) and its effect on my patient, Mr. HS, a 78 year old male. In this paper we will look at the various facets in the disease process including its incidence, pathophysiology, presenting complaints, analysis of his clinical presentation, and discuss treatment. We will analyze the effect the disease process has on Mr. HS and will examine his clinical manifestations and laboratory work, as well as provide an outcome analysis. Understanding these various facets will enable one to understand
This is a case study on a 76 year old man.Mr Alan Chari(pseudonym used to protect the identity of a patient),was admitted over night in my department.He is a divorcee who stays with son.He is a retired teacher and his son is permanently employed by a local company as an electrician.He is independent with activities of daily livings but is occasionally limited by his ill health.He used to be a heavy smoker .After realising the burden COPD has on general New Zealand population ,affecting about15% of the adult population over the age of 45 years according to asthmanz( 2010) ,l took this case study to gain in-depth understanding.
A review of his medical record indicates a medical history of COPD-chronic, CHF-chronic and NIDDM-chronic. His medical record indicates that on 10/11/16 he saw Dr Mustafa for a complaint of SOB, cough, congestion and wheezing. He was prescribed a Medrol dose pak and ABT Azithromycin. On 10/14/16 again he saw Dr Mustafa for wheezing and productive cough because he did not obtain the previously prescribed medication from the pharmacy and again on 10/21/16 he saw Dr. Mustafa for SOB, weak and dizziness at which time he was referred to palliative care.
This case involves the assessment of the client’s problems. GL is a 62-year-old retired correctional officer she has come to the emergency room with SOB on exertion and worsening fatigue for the last few months. She was diagnosed with chronic obstructive pulmonary disease (COPD) as her symptoms have become more troublesome over the past month. She was diagnosed with COPD twenty-four months ago. GL was doing well on inhaled albuterol as needed but for the past 2 months has had a persistent cough and is more breathlessness. GL is a 62 year old retired, Hispanic, catholic, female who complains of shortness of breath on exertion and worsening fatigue for the last couple of months. She has not complained of chest pain or tightness. She has noticed slight foot and ankle edema and has gotten worse over past months. GL’s medical
Introduction. Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that can affect various structures of the lungs in a different ways and result in limitation of airflow. Statistics shows that COPD is the third leading cause of death in the United States; it affects 16 million diagnosed Americans with the disease and millions more who are not aware that they live with this condition (NHLBI, 2017). Even though COPD is often preventable and treatable, it takes one life every four minutes. COPD also is the sixth largest contributor to number of years lived with disability in the United States that put a great burden on public health in many ways such as cost of life-long treatment, management the symptoms,
Chronic Obstructive Pulmonary Disease (COPD) is the result of the obstruction of the airways and of the air out of the lungs as you exhale. Not only is this condition usually permanent with attacks (called exacerbations when the attacks become worse, even life-threatening) occurring over long periods of time (hence the word “chronic” in the name of the condition), it can also become more serious with each attack. COPD is usually caused by three conditions that over time that wreak havoc on the respiratory system. These conditions are: chronic bronchitis, chronic asthma, and emphysema. However, chronic asthma is not as likely to cause COPD as the chronic bronchitis and emphysema (which the chronic bronchitis and emphysema sometimes are BOTH
Background COPD is a devastating chronic disease for those that are affected by it. Primarily comprised of chronic
As of not long ago, the significant objective of COPD treatment was the diminishment of side effects. Nonetheless, with the acknowledgment that intensifications of COPD are extremely normal, have a noteworthy antagonistic effect on personal satisfaction, and may speed sickness movement, rules and clinical consideration are concentrating on decreasing future dangers, for example, the counteractive action and treatment of intensifications (2013, August 23). In created nations the hospitalization of COPD patients, brought on transcendently by intensifications, represents over half of direct human services
Causes of COPD are, but are not limited to, tobacco smoke, occupational working exposure, outdoor and indoor pollutants, genetic factors and early life environmental factors. This disease has become the third leading cause of death in the United States of America. The only proven way to slow the progression is to QUIT smoking. Some studies have shown that giving a bronchodilator has reversed some lung function which benefits the patient. Symptoms of COPD include, but are not limited to, dyspnea upon exertion, chronic cough with or without phlegm, fatigue and weight loss. Some common characteristics of COPD are exacerbations and episodes of acute worsening. Exacerbations are commonly caused by viral and/or bacterial infections and pollution. Multimodal treatments are used and include
Chronic Obstructive Pulmonary Disease, also known as COPD, is the third leading cause of death in the United States. COPD includes extensive lungs diseases such as emphysema, non-reversible asthma, specific forms of bronchiectasis, and chronic bronchitis. This disease restricts the flow of air in and out of the lungs. Ways in which these limitations may occur include the loss of elasticity in the air sacs and throughout the airways, the destruction of the walls between air sacs, the inflammation or thickening of airway walls, or the overproduction of mucus in airways which can lead to blockage. Throughout this paper I am going to explain the main causes, symptoms, diagnosis, and ways to reduce COPD.
COPD, or Chronic Obstructive Pulmonary Disease, is one of the most common lung diseases. Thousands of people are diagnosed every year, and it recently moved up to the 3rd leading cause of death in the U.S., behind heart disease and cancer. This paper will discuss disease pathology, the most common and recently discovered diagnostic tests, as well as treatment options. It will also address end of life care.
There is no cure for this condition, but certain treatments may help a patient to feel better, remain more active and also keep their condition from progressing so fast. First, the doctor will tell you if you are a smoker the best thing to do is to quit. And, depending on the severity of your COPD your doctor may advise you to see a pulminologist, who is a doctor who treats patients with lung problems. Then, different medications may be prescribed such as bronchodilators, short-acting or long-acting again depending on the severity of the disease. Both are used to relax the muscles around your airways to help make breathing easier; however, short-acting is said to only last four to six hours, whereas, long-acting is said to last twelve hours or more. Most bronchodilators are used through metered-dose inhalers. Also, inhaled steroids may be prescribed to reduce the airways from swelling. Doctors will usually prescribe the steroid for a trial period of six weeks to three months. Other treatments to help this disease from progressing may be pulmonary rehabilitation, oxygen therapy, and vaccines to prevent the patient from the pneumonia or the flu. Rarely, a patient may be advised to have surgery such as a bullectomy, which is a removal of one or more very large bullae of the lungs, a lung volume reduction surgery, which is used to removed damaged tissue from the lungs, or a lung transplant may also benefit patients who suffer
As the number of smokers are rapidly increasing recently, the number of patients with COPD (Chronic Obstructive Pulmonary Disease) is also gradually increasing. It is one of the most common chronic diseases and is considered to be one of the five leading diseases following heart disease, pneumonia, HIV and AIDS worldwide (GOLD, 2004). Smoking is the main cause of COPD. However, long term exposure to chemical fumes and air pollution could also cause COPD. This essay is all about how COPD affects individual, family and society as a whole across their lifespan. Also, it discusses the role of a nurse in caring patients with COPD.
I will analyse the prevalence of the condition and what the potential causes may be. My interests have been directed to pre hospital care and community lead treatment packages, which are potentially available to the patient, as this is the acute environment, which I will have contact with in my employment as a paramedic. The initial reading was to understand COPD as a chronic condition, what is COPD? and its prevalence in the population. The (World health organisation, 2000), states that one in four deaths in the world are caused by COPD. In 2010 (Vos T Flaxman etal, 2012), says globally there were approximately 329 million, which is 4.8% of the population who are affected by this chronic condition, In the UK (NICE, 2010), have estimated that 3 million people suffer from COPD, with more yet to be diagnosed. This information about the amount of people living with this condition was surprising, as I little knowledge of its existence. During the early 1960’s (Timothy Q. Howes, 2005), says the term COPD had been designated as a single term unifying all the chronic respiratory diseases. Since then the term COPD, has been sub divided in to three umbrella areas, Bronchitis, Emphysema and Chronic asthma, which are separate conditions, which I have been previously aware of as their individual conditions. The 58 year old patient who we visited,
57). Despite this, the following risk factors including tobacco smoke, occupational and environmental pollution and genetic predispositions are examples of where effective preventative action could target (Decramer et al., 2012). Since the typical prognoses of COPD is that it progressively worsens and can eventually lead to death, the management and monitoring of this healthcare disorder will span over a patient’s lifetime (Fletcher & Dalh,